David S Shulman1, Preeti Mehrotra2, Traci M Blonquist3, Andrew Capraro4, Leslie E Lehmann1, Lewis B Silverman1, Neeraj K Surana5,6, Andrew E Place1. 1. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. 2. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 3. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. 4. Division of Emergency Medicine, Business Intelligence, Boston Children's Hospital, Boston, Massachusetts. 5. Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts. 6. Division of Infectious Diseases, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
Abstract
BACKGROUND: Bacillus species are known to cause severe infection in immunocompromised hosts. The incidence of Bacillus bloodstream infections and characteristics of infection among children with cancer or indication for hematopoietic cell transplant (HCT) is unknown. METHODS: We performed a retrospective medical record review of all cases of Bacillus bacteremia between January 1, 2005, and December 31, 2014, at Boston Children's Hospital. We report average incidences from 2012 to 2014. We performed a detailed review of infections among children with cancer or undergoing HCT and a case-control study to evaluate whether neutropenia at diagnosis caries higher risk of Bacillus infection for children with acute lymphoblastic leukemia (ALL). RESULTS: One hundred fourteen children developed Bacillus bacteremia during the study period, with an estimated incidence of 0.27/1,000 patients. Among children treated for cancer or undergoing HCT, there were 37 bloodstream infections (2.0/1,000 patients). Of the 37 oncology/HCT patients, oncologic diagnoses included ALL (18), acute myeloid leukemia (3), myelodysplastic syndrome (1), solid tumors (8), and 7 children were undergoing HCT. The incidence of infection among children with ALL was 34/1,000 patients and all central nervous system (CNS) infections (6) and deaths (3) occurred in this population. Neutropenia at time of diagnosis in children with ALL was not associated with risk of infection (P = 0.17). DISCUSSION: We report the first hospital-wide analysis of Bacillus infection and found that immunocompromised children experience a significant proportion of Bacillus infections. Children with ALL have a high incidence of infection and are at higher risk of CNS involvement and death.
BACKGROUND:Bacillus species are known to cause severe infection in immunocompromised hosts. The incidence of Bacillus bloodstream infections and characteristics of infection among children with cancer or indication for hematopoietic cell transplant (HCT) is unknown. METHODS: We performed a retrospective medical record review of all cases of Bacillus bacteremia between January 1, 2005, and December 31, 2014, at Boston Children's Hospital. We report average incidences from 2012 to 2014. We performed a detailed review of infections among children with cancer or undergoing HCT and a case-control study to evaluate whether neutropenia at diagnosis caries higher risk of Bacillus infection for children with acute lymphoblastic leukemia (ALL). RESULTS: One hundred fourteen children developed Bacillus bacteremia during the study period, with an estimated incidence of 0.27/1,000 patients. Among children treated for cancer or undergoing HCT, there were 37 bloodstream infections (2.0/1,000 patients). Of the 37 oncology/HCT patients, oncologic diagnoses included ALL (18), acute myeloid leukemia (3), myelodysplastic syndrome (1), solid tumors (8), and 7 children were undergoing HCT. The incidence of infection among children with ALL was 34/1,000 patients and all central nervous system (CNS) infections (6) and deaths (3) occurred in this population. Neutropenia at time of diagnosis in children with ALL was not associated with risk of infection (P = 0.17). DISCUSSION: We report the first hospital-wide analysis of Bacillus infection and found that immunocompromised children experience a significant proportion of Bacillus infections. Children with ALL have a high incidence of infection and are at higher risk of CNS involvement and death.
Authors: J C Christenson; C Byington; E K Korgenski; E E Adderson; C Bruggers; R H Adams; E Jenkins; S Hohmann; K Carroll; J A Daly; A T Pavia Journal: Am J Infect Control Date: 1999-12 Impact factor: 2.918
Authors: M K Arnaout; R F Tamburro; S M Bodner; J T Sandlund; G K Rivera; C H Pui; R C Ribeiro Journal: J Pediatr Hematol Oncol Date: 1999 Sep-Oct Impact factor: 1.289
Authors: K Kato; Y Matsumura; M Yamamoto; M Nagao; Y Ito; S Takakura; S Ichiyama Journal: Eur J Clin Microbiol Infect Dis Date: 2014-03-03 Impact factor: 3.267
Authors: Jordan R Hansford; Marianne Phillips; Catherine Cole; Joshua Francis; Christopher C Blyth; Nicholas G Gottardo Journal: J Pediatr Hematol Oncol Date: 2014-04 Impact factor: 1.289
Authors: Andrew E Place; Kristen E Stevenson; Lynda M Vrooman; Marian H Harris; Sarah K Hunt; Jane E O'Brien; Jeffrey G Supko; Barbara L Asselin; Uma H Athale; Luis A Clavell; Peter D Cole; Kara M Kelly; Caroline Laverdiere; Jean-Marie Leclerc; Bruno Michon; Marshall A Schorin; Jennifer J G Welch; Steven E Lipshultz; Jeffery L Kutok; Traci M Blonquist; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman Journal: Lancet Oncol Date: 2015-11-06 Impact factor: 41.316
Authors: Margaret Lubwama; David P Kateete; Kirabo Tess Ayazika; Winnie Nalwanga; Douglas Bruno Kagambo; Mayanja David Nsubuga; Arnold Kingston Arach; Leoson Junior Ssetaba; Joyce N Wamala; Leah Amaro Rwot; Henry Kajumbula Journal: Adv Med Educ Pract Date: 2021-10-28